75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS cash on hand 1999–2026What is a balance sheet? The balance sheet lists what a company owns (assets), what it owes (liabilities) and what is left for its shareholders (equity) on one date.
Sanofi ADS had 5.97B EUR in cash and short-term investments on 30 September 2026, down 33.0% on a year before. At the end of fiscal year 2025 it had 8.47B EUR.
Last updated 9 Nov 2026 · Next report 4 Feb 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 5.97B | -33.01% | 19.85B | -13.88B |
| FY2025 | 31 Dec 2025 | 8.47B | +6.81% | 20.33B | -11.86B |
| FY2024 | 31 Dec 2024 | 7.93B | -8.99% | 17.91B | -9.98B |
| FY2023 | 31 Dec 2023 | 8.71B | -31.61% | 18.70B | -9.99B |
| FY2022 | 31 Dec 2022 | 12.74B | +26.12% | 21.21B | -8.48B |
| FY2021 | 31 Dec 2021 | 10.10B | -27.43% | 22.41B | -12.32B |
| FY2020 | 31 Dec 2020 | 13.92B | +42.84% | 23.68B | -9.76B |
| FY2019 | 31 Dec 2019 | 9.74B | +40.68% | 25.93B | -16.19B |
| FY2018 | 31 Dec 2018 | 6.93B | -32.86% | 24.64B | -17.72B |
| FY2017 | 31 Dec 2017 | 10.32B | -0.64% | 15.60B | -5.29B |
| FY2016 | 31 Dec 2016 | 10.38B | +12.28% | 18.58B | -8.20B |
| FY2015 | 31 Dec 2015 | 9.25B | +22.32% | 16.55B | -7.31B |
| FY2014 | 31 Dec 2014 | 7.56B | -10.46% | 14.81B | -7.26B |
| FY2013 | 31 Dec 2013 | 8.44B | +28.71% | 14.59B | -6.15B |
| FY2012 | 31 Dec 2012 | 6.56B | +212.04% | 14.53B | -7.97B |
| FY2011 | 31 Dec 2011 | 2.10B | -63.88% | 15.44B | -13.34B |
| FY2010 | 31 Dec 2010 | 5.82B | +17.13% | 8.26B | -2.44B |
| FY2009 | 31 Dec 2009 | 4.97B | +7.34% | 8.83B | -3.86B |
| FY2008 | 31 Dec 2008 | 4.63B | +158.03% | 6.01B | -1.38B |
| FY2007 | 31 Dec 2007 | 1.79B | +42.27% | 5.94B | -4.15B |
| FY2006 | 31 Dec 2006 | 1.26B | -19.17% | 6.94B | -5.68B |
| FY2005 | 31 Dec 2005 | 1.56B | -37.30% | 11.18B | -9.62B |
| FY2004 | 31 Dec 2004 | 2.49B | -26.22% | 16.04B | -13.55B |
| FY2003 | 31 Dec 2003 | 3.37B | +9.12% | 367.64M | 3.00B |
| FY2002 | 31 Dec 2002 | 3.09B | -27.94% | 416.45M | 2.67B |
| FY2001 | 31 Dec 2001 | 4.29B | +48.98% | 404.00M | 3.89B |
| FY2000 | 31 Dec 2000 | 2.88B | +22.20% | 412.00M | 2.47B |
| FY1999 | 31 Dec 1999 | 2.36B | — | 461.00M | 1.90B |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 5.97B | -33.01% | 19.85B | -13.88B |
| Q2 FY2026 | 30 Jun 2026 | 6.35B | -58.66% | 23.58B | -17.23B |
| Q1 FY2026 | 31 Mar 2026 | 5.54B | -30.62% | 20.02B | -14.48B |
| Q4 FY2025 | 31 Dec 2025 | 8.47B | +6.81% | 20.33B | -11.86B |
| Q3 FY2025 | 30 Sept 2025 | 8.91B | — | 21.76B | -12.85B |
| Q2 FY2025 | 30 Jun 2025 | 15.36B | +126.03% | 22.29B | -6.93B |
| Q1 FY2025 | 31 Mar 2025 | 7.99B | -8.25% | 21.05B | -13.06B |
| Q4 FY2024 | 31 Dec 2024 | 7.93B | -8.99% | 17.91B | -9.98B |
| Q2 FY2024 | 30 Jun 2024 | 6.80B | -14.99% | 24.03B | -17.24B |
| Q1 FY2024 | 31 Mar 2024 | 8.71B | -31.61% | 0.00 | 8.71B |
| Q4 FY2023 | 31 Dec 2023 | 8.71B | -31.61% | 18.70B | -9.99B |
| Q3 FY2023 | 30 Sept 2023 | 7.99B | +15.86% | 0.00 | 7.99B |
| Q2 FY2023 | 30 Jun 2023 | 7.99B | +15.86% | 21.03B | -13.03B |
| Q1 FY2023 | 31 Mar 2023 | 12.74B | +25.99% | 0.00 | 12.74B |
| Q4 FY2022 | 31 Dec 2022 | 12.74B | +26.12% | 21.21B | -8.48B |
| Q3 FY2022 | 30 Sept 2022 | 6.90B | -29.04% | 0.00 | 6.90B |
| Q2 FY2022 | 30 Jun 2022 | 6.90B | -29.04% | 21.24B | -14.34B |
| Q1 FY2022 | 31 Mar 2022 | 10.11B | -27.35% | 0.00 | 10.11B |
| Q4 FY2021 | 31 Dec 2021 | 10.10B | -27.43% | 22.41B | -12.32B |
| Q3 FY2021 | 30 Sept 2021 | 9.72B | -39.12% | 0.00 | 9.72B |
| Q2 FY2021 | 30 Jun 2021 | 9.72B | -39.12% | 21.65B | -11.93B |
| Q1 FY2021 | 31 Mar 2021 | 13.92B | +47.55% | 0.00 | 13.92B |
| Q4 FY2020 | 31 Dec 2020 | 13.92B | +42.84% | 23.68B | -9.76B |
| Q3 FY2020 | 30 Sept 2020 | 15.97B | +136.86% | 0.00 | 15.97B |
| Q2 FY2020 | 30 Jun 2020 | 15.97B | +136.86% | 24.93B | -8.96B |
| Q1 FY2020 | 31 Mar 2020 | 9.43B | +35.60% | 0.00 | 9.43B |
| Q4 FY2019 | 31 Dec 2019 | 9.74B | +40.68% | 25.93B | -16.19B |
| Q3 FY2019 | 30 Sept 2019 | 6.74B | -10.02% | 0.00 | 6.74B |
| Q2 FY2019 | 30 Jun 2019 | 6.74B | -10.02% | 26.70B | -19.95B |
| Q1 FY2019 | 31 Mar 2019 | 6.96B | -45.66% | 0.00 | 6.96B |
| Q4 FY2018 | 31 Dec 2018 | 6.93B | -33.72% | 24.64B | -17.72B |
| Q3 FY2018 | 30 Sept 2018 | 7.49B | -31.11% | 0.00 | 7.49B |
| Q2 FY2018 | 30 Jun 2018 | 7.49B | -31.11% | 28.94B | -21.45B |
| Q1 FY2018 | 31 Mar 2018 | 12.80B | +24.18% | 27.00B | -14.20B |
| Q4 FY2017 | 31 Dec 2017 | 10.45B | +0.35% | 15.60B | -5.15B |
| Q3 FY2017 | 30 Sept 2017 | 10.88B | +75.27% | 0.00 | 10.88B |
| Q2 FY2017 | 30 Jun 2017 | 10.88B | +79.02% | 18.43B | -7.55B |
| Q1 FY2017 | 31 Mar 2017 | 10.31B | +12.03% | 0.00 | 10.31B |
| Q4 FY2016 | 31 Dec 2016 | 10.41B | +12.61% | 18.58B | -8.17B |
| Q3 FY2016 | 30 Sept 2016 | 6.21B | +25.96% | 0.00 | 6.21B |
| Q2 FY2016 | 30 Jun 2016 | 6.08B | +23.32% | 17.28B | -11.20B |
| Q1 FY2016 | 31 Mar 2016 | 9.20B | +23.52% | 0.00 | 9.20B |
| Q4 FY2015 | 31 Dec 2015 | 9.25B | +22.32% | 16.55B | -7.31B |
| Q3 FY2015 | 30 Sept 2015 | 4.93B | +12.64% | 0.00 | 4.93B |
| Q2 FY2015 | 30 Jun 2015 | 4.93B | +12.64% | 14.73B | -9.81B |
| Q1 FY2015 | 31 Mar 2015 | 7.45B | -10.70% | 0.00 | 7.45B |
| Q4 FY2014 | 31 Dec 2014 | 7.56B | -10.46% | 14.81B | -7.26B |
| Q3 FY2014 | 30 Sept 2014 | 4.37B | +2.60% | 0.00 | 4.37B |
| Q2 FY2014 | 30 Jun 2014 | 4.37B | +2.60% | 14.80B | -10.42B |
| Q1 FY2014 | 31 Mar 2014 | 8.34B | +28.76% | 0.00 | 8.34B |
| Q4 FY2013 | 31 Dec 2013 | 8.44B | +28.71% | 14.59B | -6.15B |
| Q3 FY2013 | 30 Sept 2013 | 4.26B | — | 0.00 | 4.26B |
| Q2 FY2013 | 30 Jun 2013 | 4.26B | -8.09% | 14.66B | -10.40B |
| Q1 FY2013 | 31 Mar 2013 | 6.48B | — | 0.00 | 6.48B |
| Q4 FY2012 | 31 Dec 2012 | 6.56B | +57.71% | 14.53B | -7.97B |
| Q2 FY2012 | 30 Jun 2012 | 4.64B | -30.29% | 16.18B | -11.54B |
| Q4 FY2011 | 31 Dec 2011 | 4.16B | -35.90% | 15.44B | -11.28B |
| Q2 FY2011 | 30 Jun 2011 | 6.65B | +95.56% | 20.04B | -13.39B |
| Q4 FY2010 | 31 Dec 2010 | 6.49B | +30.57% | 8.26B | -1.77B |
| Q2 FY2010 | 30 Jun 2010 | 3.40B | -46.87% | 9.57B | -6.17B |
| Q4 FY2009 | 31 Dec 2009 | 4.97B | +7.34% | 8.83B | -3.86B |
| Q2 FY2009 | 30 Jun 2009 | 6.40B | +576.26% | 9.92B | -3.52B |
| Q4 FY2008 | 31 Dec 2008 | 4.63B | +158.03% | 6.01B | -1.38B |
| Q2 FY2008 | 30 Jun 2008 | 946.82M | -19.55% | 6.54B | -5.60B |
| Q4 FY2007 | 31 Dec 2007 | 1.79B | +42.21% | 5.94B | -4.15B |
| Q2 FY2007 | 30 Jun 2007 | 1.18B | -22.00% | 6.66B | -5.48B |
| Q4 FY2006 | 31 Dec 2006 | 1.26B | -19.06% | 6.94B | -5.68B |
| Q2 FY2006 | 30 Jun 2006 | 1.51B | -44.56% | 9.95B | -8.44B |
| Q4 FY2005 | 31 Dec 2005 | 1.56B | -37.30% | 11.17B | -9.61B |
| Q2 FY2005 | 30 Jun 2005 | 2.72B | -15.34% | 15.01B | -12.29B |
| Q4 FY2004 | 31 Dec 2004 | 2.49B | -26.28% | 16.03B | -13.54B |
| Q2 FY2004 | 30 Jun 2004 | 3.21B | +41.66% | 323.02M | 2.89B |
| Q4 FY2003 | 31 Dec 2003 | 3.37B | +9.12% | 367.64M | 3.00B |
| Q2 FY2003 | 30 Jun 2003 | 2.27B | -25.35% | 306.80M | 1.96B |
| Q4 FY2002 | 31 Dec 2002 | 3.09B | — | 416.45M | 2.67B |
| Q2 FY2002 | 30 Jun 2002 | 3.04B | — | 451.96M | 2.59B |
Figures in EUR at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about Sanofi ADS's cash
Source: Financial Modeling Prep